Prospecto: information for theuser
Alprostadil Recordati 3 mg/g cream
Read this prospect carefully before starting to use this medication, because it contains important information for you.
1.What isAlprostadil Recordatiand for what it is used
2.What you need to know before starting to useAlprostadil Recordati
3.How to useAlprostadil Recordati
4.Possible adverse effects
6.Contents of the package and additional information
Alprostadil Recordati is used to treat erectile dysfunction in men 18 years of age or older. Erectile dysfunction is the inability to achieve or maintain an adequate erection for sexual intercourse. There are several causes of erectile dysfunction, including medications you may be taking for other conditions, poor blood circulation in the penis, nerve damage, emotional problems, smoking, or alcohol abuse, and hormonal problems. Often, erectile dysfunction is due to more than one cause. If you are taking a medication that causes erectile dysfunction, if your doctor has prescribed medications or medical devices that produce an erection, if you are undergoing surgical procedures to correct blood flow to the penis, penile implants, and receive psychological help, your doctor may modify your treatment.After application ofAlprostadil Recordati, the onset of erection occurs within5 to30 minutes.
You should not stop taking any prescribed medication unless your doctor tells you to.
Do not use Alprostadil Recordati
Warnings and precautions
Consult your doctor or pharmacist before starting to take Alprostadil Recordati if you have a history of the following local effects that have been observed with the use of Alprostadil Recordati:
Use a condom in the following situations:
Only latex condoms have been studied. The effect of condoms made with other materials is unknown.
Other medications and Alprostadil Recordati
Inform your doctor or pharmacist if you are taking, have taken recently or may need to take any other medication.
The use of Alprostadil Recordati with other medications for erectile dysfunction has not been studied. Therefore, if you take other medications for erectile dysfunction, do not combine them with Alprostadil Recordati as they may cause symptoms including dizziness, weakness and prolonged erections.Alprostadil Recordatihas not been evaluated for use with penile implants or smooth muscle relaxants, such as papaverine, medications used to induce erections, such as alpha blockers (e.g. fentolamine, timoxamine intracavernously). There is a risk of priapism (painful prolonged erection) when used in combination.
Although not studied, it is possible that Alprostadil Recordati may have less effect when used in combination with treatments for high blood pressure, decongestants and appetite suppressants.
If you are taking medications to prevent blood clots, do not use Alprostadil Recordati as it may increase the risk of bleeding or appearance of blood in urine.
When used with a medication for high blood pressure, the use of Alprostadil Recordati may increase symptoms of dizziness and weakness, especially in elderly patients.
Pregnancy, breastfeeding and fertility
There are no data on the use of Alprostadil Recordati in pregnant women. Pregnant women should not be exposed to Alprostadil Recordati.
The use of Alprostadil Recordati is not recommended during breastfeeding.
The effect of Alprostadil Recordati on human male fertility is unknown.
Driving and operating machinery
Alprostadil Recordati may cause dizziness or weakness. Do not drive or operate machinery within 1 to 2 hours after administration.
Alprostadil Recordati contains ethanol
This medication contains 5 mg of alcohol (ethanol) in each 100 mg dose, which is equivalent to 50 mg/g (5% p/p). It may cause a burning sensation on damaged skin.
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Alprostadil Recordatiis available in doses of 200 and 300 micrograms of alprostadil in 100 milligrams of cream.Alprostadil Recordatimust be used when needed to achieve an erection. Each package ofAlprostadil RecordatiAccuDose is for single use and must be disposed of properly after use.
For an erection:your doctor must recommend the initial dose.Do not adjust the dose on your own.Consult your doctor who will instruct you on the proper technique for administration and adjustment of your dose.
Do not use Alprostadil Recordati more than 2-3 times a week and only once within a 24-hour period.
The onset of effect occurs within5 to30 minutes after administration. The effect usually lasts approximately between 1 and 2 hours. However, the actual duration may vary among patients.
It is recommended to urinate before applying the medication. After removing the cap from the package (cap), apply the entire contents ofAlprostadil Recordatito the tip of the penis within5 to30 minutes before attempting intercourse following the instructions indicated below:
Plunger Body Tip Cap or cap |
Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Use in children and adolescents
Alprostadil Recordatiis not indicated for use in children or individuals under 18 years of age.
If you use more Alprostadil Recordati than you should
No overdose withAlprostadil Recordatihas been reported that requires treatment. An overdose withAlprostadil Recordatimay cause a drop in blood pressure, dizziness, nausea, persistent pain in the penis, and possible prolonged erection with a duration exceeding 4 hours. This may cause permanent deterioration of erectile function.Call your doctor immediately if you experience any of these effects.
In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicological Information Service, phone: 91 562 04 20 indicating the medication and the amount ingested.
If you have any doubts, consult your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
If you get an erection that lasts more than 4 hours, contact your doctor immediately.
Your doctor may reduce your dose ofAlprostadil Recordatiand stop your treatment.
Common side effects (may affect more than 1 in 10 patients):
You:
Your partner:
-Mild vaginal burning or itching, vaginitis
This effect may be due to the medication or vaginal penetration. Using a water-based lubricant may facilitate vaginal penetration.
Less common but potentially serious side effects (may affect up to 1 in 100 patients):
You:
Your partner: vulvovaginal itching
*Increased sexual or physical activity in combination withAlprostadil Recordatimay increase the risk of heart attack or stroke in patients with underlying disease or risk factors (see section 2).
Duration of side effects:
Most side effects are of short duration and resolve within1 to2 hours.
Reporting side effects
If you experience any type of side effect, consult your doctor, even if it is a possible side effect not listed in this leaflet. You can also report them directly through theSpanish System for Pharmacovigilance of Medicinal Products for Human Use:https://www.notificaram.es.
By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the box, the pouch, the AccuDose device label after CAD.
The expiration date is the last day of the month indicated.
Store in the refrigerator (between 2 °C and 8 °C).
Do not freeze.
The patient may keep the unopened pouches outside the refrigerator, at a temperature below 25 °C for up to 3 days before use.
At the end of this period, the product must be discarded if not used.
Each dosifier is for single use.
Once opened, use immediately, discard any unused portion.
Store in the original pouch to protect it from light.
Medications should not be thrown down the drains or in the trash.Deposit the containers and medications that you no longer need in the SIGRE collection point at the pharmacy.If in doubt, ask your pharmacist how to dispose of the containers and medications that you no longer need.By doing so, you will help protect the environment.
Composition of Alprostadil Recordati
Each individual package contains 300 micrograms of alprostadil in 100 milligrams of cream(3mg/g).
Alprostadil Recordatiis available in unit cartons with four (4) single-dose packages.
Appearance of the product and contents of the package
Alprostadil Recordatiis a white to off-white paste supplied in AccuDose, a single-dose package. AccuDose is a package consisting of a plunger, a cylinder, and a protective closure capsule.
Each package is supplied in a protective overwrap.
The overwraps are composed of laminated/aluminum foil. The components of the package are polypropylene and polyethylene.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization:
Recordati Ireland Ltd.
Raheens East
Ringaskiddy Co.Cork
Irlanda
Tel. +353 (0) 21 4379 400
Fax +353 (0) 21 4379 2800
Local representative:
Casen Recordati, S.L.
Autovía de Logroño, km. 13,300. 50180 Utebo (Zaragoza).
España
Responsible for manufacturing:
Recordati Industria Chimica e Farmaceutica S.p.A.
Via M. Civitali, 1
20148 Milán
Italia
Casen Recordati, S.L.
Autovía de Logroño, km. 13,300. 50180 Utebo (Zaragoza).
España
This medicinal product is authorized in the Member States of the European Economic Area with the following names:
Member State | Medicinal product name |
Netherlands | Alprostadil Recordati 3mg/g Crème |
Cyprus | Vitaros 3 mg/g |
Czech Republic | Vitaros 3 mg/g Krém |
Greece | Vitaros 3mg/g |
Ireland | Vitaros 3 mg/g Cream |
Portugal | Vitaros 3 mg/g Creme |
Romania | Vitaros 3 mg/g Crema |
Slovakia | Vitaros 3 mg/g Krém |
Spain | Alprostadil Recordati 3 mg/g Crema |
Last review date of this leaflet: May 2023
Other sources of information
Detailed and updated information on this medicinal product is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
_________________________________________________________________________________
EFFECTS AFTER APPLICATION
Alprostadil Recordatirequires between 5 and 30 minutes before it starts to work and before you can have sexual intercourse.
After administration, you can use sexual stimulation to help with excitement and the process of developing an erection. A successful dose ofAlprostadil Recordatishould produce a suitable erection for sexual intercourse. The duration of the effect is approximately between 1 and 2 hours. However, the actual duration will be variable between patients and the dose of the drug.Alprostadil Recordatimay not produce an erection comparable to those you experienced when you were younger. Some patients may experience a little mild pain, a burning sensation, and pain in the penis or inguinal area. Additionally, your erection may continue for some time after orgasm or ejaculation. After your erection has ended, your penis may feel full, warm, and slightly sensitive to the touch. These effects are normal and may last for a few hours.
ADDITIONAL INFORMATION AND PRACTICAL ADVICE
You and your doctor will determine the appropriate dose ofAlprostadil Recordati. If your erection cannot be maintained for the necessary time for sexual stimulation or sexual intercourse, you will need to increase the dose. Similarly, if an erection lasts longer than desired or if adverse reactions are not well tolerated, you will need to reduce your dose. Call your doctor if you suspect you need a dose adjustment.
Factors that may increase your erection:
-Feeling well rested.
-Sexual stimulation with your partner or self-stimulation when you feel or lie down after applyingAlprostadil Recordati.
-Kegel exercises such as tensing and relaxing the pelvic muscles and gluteal muscles. These are the muscles you use to interrupt urination.
-Several positions that may favor and not limit blood flow to the penis.
Factors that may reduce your erection:
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.